Product
Efavirenz+TGRX-326
1 clinical trial
1 indication
Indication
Lung CancerClinical trial
An Open-label, Two-cycle, Single Sequence, Self-controlled Study Evaluating Effects of Oral Itraconazole or Efavirenz on Pharmacokinetic Profiles of TGRX-326Status: Recruiting, Estimated PCD: 2024-04-30